Epidermal growth factor receptor (EGFR) is an important target for cancer therapeutic agents because it is expressed in many types of solid tumor and its expression level is correlated with malignancy, metastatic phenotype, and poor prognosis 12, 13, 14. This evidence concerns the gene EGFR and cancer.